United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for CollPlant Biotechnologies Ltd? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -79.46% | -7.03% | -7.93% | -9.73% | -11.63% | -14.26% |
|---|---|---|---|---|---|---|
| ROA | -62.87% | -4.81% | -4.89% | -5.33% | -5.54% | -5.77% |
| Gross Margin | -215.53% | 15% | 15% | 15% | 15% | 15.19% |
| Total Assets | $18,710.00K | $19,265.88K | $19,867.41K | $20,518.36K | $21,222.82K | $21,985.20K |
| Net Income | -$16,609.00K | -$914.23K | -$956.76K | -$1,113.14K | -$1,197.01K | -$1,290.28K |